Northeast Financial Consultants’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-8,959
| Closed | -$411K | – | 336 |
|
|
2022
Q1 | $411K | Buy |
8,959
+998
| +13% | +$45.8K | 0.02% | 256 |
|
|
2021
Q4 | $488K | Sell |
7,961
-5,729
| -42% | -$351K | 0.03% | 224 |
|
|
2021
Q3 | $1.02M | Sell |
13,690
-4,055
| -23% | -$303K | 0.07% | 158 |
|
|
2021
Q2 | $1.64M | Sell |
17,745
-1,731
| -9% | -$160K | 0.11% | 112 |
|
|
2021
Q1 | $1.73M | Buy |
19,476
+2,045
| +12% | +$182K | 0.13% | 95 |
|
|
2020
Q4 | $1.63M | Buy |
17,431
+11,356
| +187% | +$1.06M | 0.13% | 94 |
|
|
2020
Q3 | $386K | Buy |
+6,075
| New | +$386K | 0.03% | 199 |
|